THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRACEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSON'S DISEASECORSINI GU; DEL ZOMPO M; GESSA GL et al.1979; LANCET; GBR; DA. 1979; NO 8123; PP. 954-956; BIBL. 22 REF.Article

EVIDENCE FOR DOPAMINE RECEPTORS IN THE HUMAN BRAIN MEDIATING SEDATION AND SLEEP.CORSINI GU; DEL ZOMPO M; MANCONI S et al.1977; LIFE SCI.; G.B.; DA. 1977; VOL. 20; NO 9; PP. 1613-1618; BIBL. 17 REF.Article

DRUGGS ACTING ON DOPAMINE RECEPTORS: USEFULNESS OF A PERIPHERAL BLOCKER IN PARKINSON'S DISEASECORSINI GU; DEL ZOMPO M; TOCCO F et al.1980; PHARMACOL. RES. COMMUNIC.; GBR; DA. 1980; VOL. 12; NO 7; PP. 699-707; BIBL. 2 P.Article

INCREASED PAROXYSMAL ACTIVITY OF PARTIAL SEIZURES IN MAN BY APOMORPHINEDEL ZOMPO M; TOCCO F; MARROSU F et al.1983; PSYCHOPHARMACOLOGIA; ISSN 0033-3158; DEU; DA. 1983; VOL. 79; NO 2-3; PP. 209-214; BIBL. 34 REF.Article

PARKINSONISM BY HALOPERIDOL AND PERIBEDILCORSINI GU; DEL ZOMPO M; SPISSU A et al.1978; PSYCHOPHARMACOLOGY; DEU; DA. 1978; VOL. 59; NO 2; PP. 139-141; BIBL. 11 REF.Article

Dopamine hypersensitivity in migraine : role in apomorphine syncopeDEL ZOMPO, M; LAI, M; LOI, V et al.Headache. 1995, Vol 35, Num 4, pp 222-224, issn 0017-8748Article

A double-blind study of minaprine versus amitriptyline in major depressionDEL ZOMPO, M; BERNARDI, F; BURRAI, C et al.Neuropsychobiology. 1990, Vol 24, Num 2, pp 79-83, issn 0302-282XArticle

Therapeutic efficacy of a partial dopamine agonist in drug-free parkinsonian patientsCORSINI, G. U; BONUCELLI, U; RAINER, E et al.Journal of neural transmission. 1985, Vol 64, Num 2, pp 105-111, issn 0300-9564Article

Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamineVACCARI, A; DEL ZOMPO, M; MELIS, F et al.British journal of pharmacology. 1991, Vol 104, Num 3, pp 573-574, issn 0007-1188Article

Linkage between X-chromosome markers and mani-depressive illnessDEL ZOMPO, M; BOCCHETTA, A; GOLDIN, L. R et al.Acta psychiatrica Scandinavica. 1984, Vol 70, Num 3, pp 282-287, issn 0001-690XArticle

Localization of MPP⁺ binding sites in the brain of various mammalian speciesDEL ZOMPO, M; PICCARDI, M. P; RUIU, S et al.Journal of neural transmission - Parkinson's disease and dementia section. 1992, Vol 4, Num 3, pp 181-190, issn 0936-3076Article

High-affinity binding of [³H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes : putative vesicular locationDEL ZOMPO, M; PICCARDI, M. P; RUIU, S et al.European journal of pharmacology. 1991, Vol 202, Num 2, pp 293-294, issn 0014-2999Article

Involvement of monoamine oxidase enzymes in the action of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a selective neurotoxin, in the squirrel monkey: binding and biochemical studiesDEL ZOMPO, M; PICCARDI, M. P; BERNARDI, F et al.Brain research. 1986, Vol 378, Num 2, pp 320-324, issn 0006-8993Article

Inhibition of [³H]-MPTP binding to rat brain by pargylineDEL ZOMPO, M; BOCCHETTA, A; PICCARDI, M. P et al.Biochemical pharmacology. 1984, Vol 33, Num 24, pp 4105-4107, issn 0006-2952Article

Peripheral benzodiazepine binding sites in kidney: modifications by Diabetes insipidusDEL ZOMPO, M; SAAVEDRA, J. M; CHEVILLARD, J et al.Life sciences (1973). 1984, Vol 35, Num 21, pp 2095-2103, issn 0024-3205Article

Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attemptsBOCCHETTA, A; ARDAU, R; BURRAI, C et al.Journal of clinical psychopharmacology. 1998, Vol 18, Num 5, pp 384-389, issn 0271-0749Article

Differential interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of [³H]tyramine in dopaminergic and nondopaminergic brain regionsVACCARI, A; SABA, P. L; GESSA, G. L et al.Journal of neurochemistry. 1993, Vol 60, Num 2, pp 758-760, issn 0022-3042Article

Correspondence between ³H-MPP⁺ binding site and MAO-A enzyme: pharmacological evidencesRUIU, S; PICCARDI, M. P; CORSINI, G. U et al.Pharmacological research. 1989, Vol 21, pp 15-16, issn 1043-6618, suppl. 1Conference Paper

Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivoCORSINI, G. U; BOCCHETTA, A; ZUDDAS, A et al.Biochemical pharmacology. 1988, Vol 37, Num 21, pp 4163-4169, issn 0006-2952Article

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitroBOCCHETTA, A; PICCARDI, M. P; DEL ZOMPO, M et al.Journal of neurochemistry. 1985, Vol 45, Num 3, pp 673-676, issn 0022-3042Article

A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressivesBOCCHETTA, A; BERNARDI, F; BURRAI, C et al.Acta psychiatrica Scandinavica. 1993, Vol 88, Num 6, pp 434-439, issn 0001-690XArticle

Characterization of a putatively vesicular binding site for [³H]MPP⁺ in mouse striatal membranesDEL ZOMPO, M; PICCARDI, M. P; RUIU, S et al.Brain research. 1992, Vol 571, Num 2, pp 354-357, issn 0006-8993Article

[³H]1-methyl-4-phenyl-2,3-dihydropyridinium ion binding sites in mouse brain : pharmacological and biological characterizationDEL ZOMPO, M; RUIU, S; MAGGIO, R et al.Journal of neurochemistry. 1990, Vol 54, Num 6, pp 1905-1910, issn 0022-3042Article

A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidaseCORSINI, G. U; PINTUS, S; BOCCHETTA, A et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 238, Num 2, pp 648-652, issn 0022-3565Article

Carbamazepine augmentation in lithium-refractory bipolar patients : A prospective study on long-term prophylactic effectivenessBOCCHETTA, A; CHILLOTTI, C; SEVERINO, G et al.Journal of clinical psychopharmacology. 1997, Vol 17, Num 2, pp 92-96, issn 0271-0749Article